Everest Medicines, Kezar Life Sciences get China IND approval for PALIZADE trial
PremiumThe FlyEverest Medicines, Kezar Life Sciences get China IND approval for PALIZADE trial
7M ago
Kezar Life Sciences reports Q3 EPS (32c), consensus (35c)
Premium
The Fly
Kezar Life Sciences reports Q3 EPS (32c), consensus (35c)
10M ago
Kezar Life Sciences downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Kezar Life Sciences downgraded to Hold from Buy at JonesResearch
12M ago
Kezar Life Sciences trading halted, news pending
PremiumThe FlyKezar Life Sciences trading halted, news pending
12M ago
Kezar Life Sciences price target raised to $20 from $18 at H.C. Wainwright
Premium
The Fly
Kezar Life Sciences price target raised to $20 from $18 at H.C. Wainwright
12M ago
Kezar Life Sciences enters into collaboration pact with Everest Medicines
Premium
The Fly
Kezar Life Sciences enters into collaboration pact with Everest Medicines
1y ago
KZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsKZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1y ago
William Blair downgrades Kezar on lack of near-term catalysts
Premium
The Fly
William Blair downgrades Kezar on lack of near-term catalysts
2y ago
Kezar downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Kezar downgraded to Market Perform from Outperform at William Blair
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100